Business · 29/04/2002Updated: 10/17/2026 · 1 min read
Novartis Pharmaceuticals Corp. et al.; Withdrawal of FDA Approval for 38 New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 38 new drug applications (NDAs) following notification from the applications' holders that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →